ACE2 and COVID-19: Human ACE2 (hACE2) transgenic mouse models have provided important insights into the pathogenesis of COVID-19 in terms of evaluating the efficacy and duration of immune responses elicited in response to infection as well as testing vaccines, antiviral drugs and monoclonal antibody therapies to restrict viral replication and limit disease severity (8).